Dr. Jeffrey Mumm is one of the most recent additions to the Choroideremia research team. Among his laboratory’s interests is the opportunity to perform large-scale screens of diseases to identify potential mechanisms of disease as well as possible therapeutic targets. Dr. Mumm will utilize a zebrafish model of Choroideremia to perform high-throughput screening of a large quantity of pharmaceutical and chemical compounds to identify those which increase zebrafish lifetimes. These high-throughput screening techniques can enable his laboratory to screen over 50,000 fish per day, which significantly accelerates the screening process. Those compounds could then be further investigated to determine how they work and whether they could be utilized as treatments for Choroideremia patients. Dr. Mumm is currently performing a similar study on a form of Retinitis Pigmentosa.